BIO's policy agenda, UK's Blair featured highlights at 2011 biotech conference
This article was originally published in Scrip
Executive Summary
After the struggles of staying afloat during the venture capital drought of the last decade, one of the greatest challenges currently facing the biotech industry is remaining relevant and keeping its issues visible with lawmakers in a climate of budget slashing and an upcoming oxygen-sucking US presidential campaign.